The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Current Concepts
PreviousPrevious
Volume 345:425-432 August 9, 2001 Number 6
NextNext

Toxic Leukoencephalopathy
Christopher M. Filley, M.D., and B.K. Kleinschmidt-DeMasters, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Leukoencephalopathy is a structural alteration of cerebral white matter in which myelin suffers the most damage. Toxic leukoencephalopathy may be caused by exposure to a wide variety of agents, including cranial irradiation, therapeutic agents, drugs of abuse, and environmental toxins.1 Toxic leukoencephalopathy particularly involves white-matter tracts devoted to higher cerebral function, causing clinical features that range from inattention, forgetfulness, and changes in personality to dementia, coma, and death. This review focuses on white-matter damage caused by toxins as distinguished from that caused by disorders such as multiple sclerosis, cerebrovascular disease, and metabolic disturbances.2

Although the prevalence of toxic leukoencephalopathy is . . . [Full Text of this Article]

Clinical Presentation

Diagnosis

White-Matter Toxins

Therapeutic Agents

Drugs of Abuse

Environmental Toxins

Occupational Exposure to Solvents

Prevention and Treatment

Conclusions


Source Information

From the Departments of Neurology (C.M.F., B.K.K.-D.), Pathology, (B.K.K.-D.), and Psychiatry (C.M.F.), University of Colorado School of Medicine, and the Denver Veterans Affairs Medical Center (C.M.F.) — both in Denver.

Address reprint requests to Dr. Filley at the Behavioral Neurology Section, UCHSC B-183, 4200 E. Ninth Ave., Denver, CO 80262, or at christopher.filley@uchsc.edu.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.